Suppr超能文献

钙拮抗剂减轻左心室负荷。

Left ventricular unloading with calcium antagonists.

作者信息

Guazzi M D

出版信息

G Ital Cardiol. 1984 Sep;14(9):694-8.

PMID:6239802
Abstract

Calcium channel blockers reduce the arterial smooth muscle tone and lower blood pressure. They may be regarded as left ventricular unloading agents. Left ventricular unloading efficacy of nifedipine (15 cases) and verapamil (14 cases) was tested in hypertensive decompensated patients, through one-month treatment period. Nifedipine persistently reduced systemic vascular resistance, mean arterial pressure, mean pulmonary wedge pressure and left ventricular diastolic diameter and improved cardiac index and velocity of circumferential fiber shortening. All of the patients had relief from dyspnea and reduction in heart size. The only side effect was ankle edema in 6 cases. Verapamil reduced systemic vascular resistance and mean arterial pressure and was not effective on mean pulmonary wedge pressure, left ventricular diastolic diameter and velocity circumferential fiber shortening. The drug was discontinued in 2 patients who developed severe dyspnea at rest after a 3-4 day continued oral treatment. Clinical symptoms and signs did not improve in the remaining subjects despite persistent pressure reduction. A less potent vasodilating action of verapamil and a prominent depression in cardiac contractility may account for the different results with the two compounds, in spite of a shared vasodilating antihypertensive effect. These findings prove that functional changes in the failing hypertensive heart may differ from one calcium blocker to another as a result of interaction and relative preponderance of influences on afterload and contractility.

摘要

钙通道阻滞剂可降低动脉平滑肌张力并降低血压。它们可被视为左心室减负药物。在高血压失代偿患者中,通过为期一个月的治疗期,对硝苯地平(15例)和维拉帕米(14例)的左心室减负效果进行了测试。硝苯地平持续降低全身血管阻力、平均动脉压、平均肺楔压和左心室舒张直径,并改善心脏指数和圆周纤维缩短速度。所有患者的呼吸困难均得到缓解,心脏大小缩小。唯一的副作用是6例出现踝关节水肿。维拉帕米降低全身血管阻力和平均动脉压,但对平均肺楔压、左心室舒张直径和圆周纤维缩短速度无效。在持续口服治疗3 - 4天后,2例出现静息时严重呼吸困难的患者停用了该药物。尽管血压持续降低,但其余受试者的临床症状和体征并未改善。尽管维拉帕米和硝苯地平都有血管舒张降压作用,但维拉帕米较弱的血管舒张作用和明显的心脏收缩力抑制可能是这两种化合物产生不同结果的原因。这些发现证明,由于对后负荷和收缩力的相互作用及相对优势影响,衰竭的高血压心脏的功能变化可能因钙通道阻滞剂的不同而有所差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验